Thermoresponsive Hydrogel-Fiber Composite Embolization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current embolization methods using platinum coils are vessel-specific, costly, cause imaging artifacts, and require skilled delivery, while existing materials lack versatility and effectiveness in controlling undesired bleeding.
Innovation Solution
A crosslinked hydrogel-fiber composite with macropores and interfacial bonding, suitable for catheter delivery, which includes a thermoresponsive component for in situ stiffening and enhanced mechanical properties, allowing for versatile vessel occlusion and improved embolization efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If platinum coils are used for embolization, then vessel occlusion is achieved, but the procedure becomes highly vessel-specific and requires significant skill for delivery
Solution Approach 1:
The patent employs a composite material system consisting of a hydrogel matrix combined with thermoresponsive particles. This composite structure enables the embolic agent to exhibit both deformability for easy catheter delivery and stable occlusion after deployment, resolving the contradiction between delivery ease and embolization reliability
Solution Approach 2:
The thermoresponsive particles undergo parameter changes in response to temperature variations. During delivery at lower temperatures, the particles remain soft and deformable, facilitating catheter passage. Upon contact with physiological temperature blood, they transition to a rigid state, ensuring reliable vessel occlusion without requiring high delivery skill
2Reliability
If platinum coils are used for embolization, then vessel occlusion is achieved, but imaging artifacts are generated in CT scans
Solution Approach 1:
The patent replaces expensive, permanent platinum coils with biodegradable thermoresponsive particles. These particles achieve the occlusion function temporarily and then degrade, eliminating the long-term imaging artifact problem associated with permanent metallic implants while maintaining reliable vessel occlusion
Solution Approach 2:
The thermoresponsive particles undergo parameter changes in response to temperature variations. During delivery at lower temperatures, the particles remain soft and deformable, facilitating catheter passage. Upon contact with physiological temperature blood, they transition to a rigid state, ensuring reliable vessel occlusion without requiring high delivery skill
3Reliability
If platinum coils are used for embolization, then vessel occlusion is achieved, but the cost is high
Solution Approach 1:
The patent replaces expensive platinum coils with biodegradable thermoresponsive particles. These particles achieve the occlusion function temporarily and then degrade, eliminating the long-term imaging artifact problem associated with permanent metallic implants while maintaining reliable vessel occlusion
Solution Approach 2:
The thermoresponsive particles undergo parameter changes in response to temperature variations. During delivery at lower temperatures, the particles remain soft and deformable, facilitating catheter passage. Upon contact with physiological temperature blood, they transition to a rigid state, ensuring reliable vessel occlusion without requiring high delivery skill
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composite provides a versatile and effective embolization solution that can be delivered through a catheter, suitable for a range of vessel sizes and morphologies, with enhanced stiffness and stability at physiological temperatures, improving embolus stability and reducing the need for precise vessel matching.
Implementation Method 1
a thermoresponsive component for in situ stiffening
Implementation Method 2
a crosslinked hydrogel material
Implementation Method 3
a crosslinked hydrogel material
Implementation Method 4
Preferred compositions are macroporous and thus may contain a distribution or pores that have a pore size of at least about 10 microns
Data Source
AI summary
Embolization compositions and methods for controlling undesired bleeding and other treatments are provided. Preferred composition may comprise (a) a crosslinked hydrogel material; and (b) a fiber material, wherein the composition comprises a plurality of macropores; and the hydrogel material and fiber material are bonded by covalent and/or non-covalent bonds.


